We identify potential investments through deep sector research and assess our capability in full partnership with their management teams to build market-leading and innovative companies.
2022
Laboratoire X.O is a leading pan-European distributor of over-the-counter drugs across various therapeutic areas.
2022
Qinecsa is a leading global provider of pharmacovigilance software and outsourced services to support its global pharma customers across their clinical safety and PV commitments.
2021
Healthcare AI Acquisition Corp. is Stanley Capital’s Healthcare Services and Software SPAC listed on NASDAQ under the ticker HAIA
2020
Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines.
2020
Essential is a portfolio company of a European focused private equity fund. Simon Cottle led the origination of the investment in the company and was co-lead on the execution of the transaction